The FDA has cleared TumorSight Risk, software that uses a patient's existing breast MRI, pathology and clinical information to estimate the chance that early HR-positive, HER2-negative breast cancer will come back within five and 10 years.
|Articles|March 8, 2021
7 Recent Updates in the Field of Women's Cancers
Author(s)Ryan McDonald
In honor of International Women’s Day, CURE® compiled some recent news and updates in women’s cancers that patients, survivors and caregivers may have missed.
Advertisement
There have been multiple updates in the field of women’s cancers over the past several months. In honor of International Women’s Day, CURE® looks back at some of the latest news and updates affecting women with breast, ovarian and other women’s cancers.
- Radiation after initial cancer treatment in women with uterine carcinosarcomas may reduce the rate of distant metastases (cancer development in another part of the body), according to recent study results.
READ MORE . - A patient with metastatic breast cancer recalls how she connected with the Breast Cancer Recurrence Project and how the project aims to revolutionize and bring accuracy to what is already known about those who live with metastatic breast cancer.
READ MORE .
- A breast cancer survivor shares how she recently looked back at her journey with wigs, or “the girls” as she called them, during her early part of treatment.
READ MORE . - Although a gynecologic oncologist has spent a good part of her career helping patients during their cancer journeys, she took it upon herself to take one step further to educate women on how they can advocate for themselves and potentially prevent cancer before it impacts their lives.
READ MORE . - An ovarian cancer survivor shares that although she’s been frustrated and mad about a recent recurrence in her lymph nodes, she still celebrates the life that she’s been blessed with.
READ MORE . - Even as chemotherapy, surgery and radiation remain treatment mainstays in triple-negative breast cancer, immunotherapy is ready to take the stage.
READ MORE . - The Society of Breast Imaging has recommended women wait four to six weeks after receiving their second dose of a COVID-19 vaccine to get a screening mammogram. However, experts differ on whether women should wait to get a screening mammogram following their vaccine.
READ MORE .
For more news on cancer updates, research and education, don’t forget to
Advertisement
Related to this article
Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the gratitude of living beyond cancer.
In a randomized trial of nearly 100,000 women in Germany, 3D mammography found a larger share of breast cancers at the screening visit, but its 24% lower rate of cancers found between screenings was not statistically significant.
Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed her care.
Debbie Legault, whose daughter was diagnosed with breast cancer at 27, urges shoppers to skip pink ribbon products and donate directly to support organizations.
Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter explains why getting a second opinion changed the course of her care.
Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch.
In the phase 3 RT CHARM trial, published Oct. 12, 2026, in the Journal of Clinical Oncology, a three-week course of radiation after mastectomy caused about the same rate of reconstruction complications as the standard five-week course in women with breast cancer.
Advertisement
Advertisement
Trending on CURE
1
Diagnosed With Sarcoma at 21, She Found Her People at Mary's Place
2
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
3
How a Cancer Survivor Learned to Stop Hiding His Surgical Scars
4
New Mom With Stage 4 Breast Cancer Finds Hope in a Second Opinion
5